Do statins reduce the cardiovascular risk in patients with rheumatoid arthritis? (Q38220433)

31 August 2017

title

Do statins reduce the cardiovascular risk in patients with rheumatoid arthritis? (English)

1 reference

31 August 2017

0 references

Kathrin Danninger

1

1 reference

31 August 2017

Uta C Hoppe

series ordinal

2

1 reference

31 August 2017

Herwig Pieringer

series ordinal

3

1 reference

31 August 2017

language of work or name

1 reference

16 June 2014

1 reference

International Journal of Rheumatic Diseases

31 August 2017

published in

1 reference

31 August 2017

volume

17

1 reference

31 August 2017

issue

6

1 reference

31 August 2017

page(s)

606-611

1 reference

Cardiovascular morbidity and mortality in patients with rheumatoid arthritis: vascular alterations and possible clinical implications

31 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2F1756-185X.12415

Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1756-185X.12415

Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS/TexCAPS. Air Force/Texas Coronary Atherosclerosis Prevention Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1756-185X.12415

Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial--Lipid Lowering Arm (ASCOT-LLA): a multicentre ra

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1756-185X.12415

Relationship between plasma LDL concentrations during treatment with pravastatin and recurrent coronary events in the Cholesterol and Recurrent Events trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1756-185X.12415

Prevention of Cardiovascular Events and Death with Pravastatin in Patients with Coronary Heart Disease and a Broad Range of Initial Cholesterol Levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1756-185X.12415

Usefulness of risk scores to estimate the risk of cardiovascular disease in patients with rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1756-185X.12415

Lipid paradox in rheumatoid arthritis: the impact of serum lipid measures and systemic inflammation on the risk of cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1756-185X.12415

Intensive lipid lowering in patients with rheumatoid arthritis and previous myocardial infarction: an explorative analysis from the incremental decrease in endpoints through aggressive lipid lowering (IDEAL) trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1756-185X.12415

Effect of intensive lipid-lowering therapy on cardiovascular outcome in patients with and those without inflammatory joint disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1756-185X.12415

Impact of statin discontinuation on mortality in patients with rheumatoid arthritis: a population-based study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1756-185X.12415

Primary prevention of cardiovascular diseases with statin therapy: a meta-analysis of randomized controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1756-185X.12415

HDL protein composition alters from proatherogenic into less atherogenic and proinflammatory in rheumatoid arthritis patients responding to rituximab

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1756-185X.12415

Statin adverse effects : a review of the literature and evidence for a mitochondrial mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1756-185X.12415

Persistence with Statins and Onset of Rheumatoid Arthritis: A Population-Based Cohort Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1756-185X.12415

ESC/EAS Guidelines for the management of dyslipidaemias: the Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1756-185X.12415

EULAR evidence-based recommendations for cardiovascular risk management in patients with rheumatoid arthritis and other forms of inflammatory arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2F1756-185X.12415

21 January 2018

Identifiers

DOI

10.1111/1756-185X.12415

1 reference

31 August 2017

1 reference